Status:
UNKNOWN
Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer
Lead Sponsor:
Aarhus University Hospital
Conditions:
Bladder Cancer
Radiation Therapy Complication
Eligibility:
MALE
18+ years
Brief Summary
Bladder cancer is often treated with cystectomy or radiation therapy. Following radiation therapy patients will often have severe side effects from the treatment. Studies have suggested that simultano...
Detailed Description
Bladder cancer (BC) is one of the most frequent cancers in the world and more common in men than female. Gender-related factors may be involved in the pathogenesis of BC. Studies have suggested that ...
Eligibility Criteria
Inclusion
- T2-T4 bladder cancer
- radiation therapy
- able to fill out questionnaires
- signed informed consent
Exclusion
- KAD prior to TUR-B
- dementia or other cognitive impairment
- metastatic disease
Key Trial Info
Start Date :
February 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04282876
Start Date
February 19 2020
End Date
October 31 2025
Last Update
August 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8200